Tenaya Therapeutics, Inc. Shares Outstanding (Cover Page)
Tenaya Therapeutics, Inc. (TNYA) had Shares Outstanding (Cover Page) of 224.23 million shares as of 2026-07-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-07-30: Entity Common Stock, Shares Outstanding 224.23M shares.
- 2026-05-01: Entity Common Stock, Shares Outstanding 217.00M shares.
- 2026-03-05: Entity Common Stock, Shares Outstanding 217.00M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 166.51M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-30 | 224.23M shares 10-Q · filed 2026-08-05 |
| 2026-05-01 | 217.00M shares 10-Q · filed 2026-05-06 |
| 2026-03-05 | 217.00M shares 10-K · filed 2026-03-11 |
| 2025-11-04 | 166.51M shares 10-Q · filed 2025-11-10 |
| 2025-07-31 | 162.98M shares 10-Q · filed 2025-08-06 |
| 2025-05-01 | 162.67M shares 10-Q · filed 2025-05-07 |
| 2025-03-04 | 87.58M shares 10-K · filed 2025-03-10 |
| 2024-10-31 | 79.22M shares 10-Q · filed 2024-11-06 |
| 2024-08-01 | 78.89M shares 10-Q · filed 2024-08-08 |
| 2024-05-06 | 78.52M shares 10-Q · filed 2024-05-14 |
| 2024-03-01 | 78.52M shares 10-K · filed 2024-03-18 |
| 2023-11-02 | 68.11M shares 10-Q · filed 2023-11-08 |
| 2023-08-03 | 67.87M shares 10-Q · filed 2023-08-09 |
| 2023-05-04 | 66.87M shares 10-Q · filed 2023-05-10 |
| 2023-03-02 | 66.87M shares 10-K · filed 2023-03-08 |
| 2022-11-02 | 41.37M shares 10-Q · filed 2022-11-10 |
| 2022-08-03 | 41.36M shares 10-Q · filed 2022-08-10 |
| 2022-05-06 | 41.31M shares 10-Q · filed 2022-05-11 |
| 2022-03-17 | 41.29M shares 10-K · filed 2022-03-23 |
| 2021-11-01 | 41.28M shares 10-Q · filed 2021-11-10 |
| 2021-09-02 | 41.28M shares 10-Q · filed 2021-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |